Literature DB >> 18825741

The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells.

Johanna Kober1, Judith Leitner, Christoph Klauser, Ramona Woitek, Otto Majdic, Johannes Stöckl, Dietmar Herndler-Brandstetter, Beatrix Grubeck-Loebenstein, Birgit M Reipert, Winfried F Pickl, Katharina Pfistershammer, Peter Steinberger.   

Abstract

Activating signals generated by members of the tumour necrosis factor receptor superfamily upon interaction with their cognate ligands play important roles in T-cell responses. Members of the tumour necrosis factor family namely 4-1BBL, OX40L, CD70, GITRL, LIGHT and CD30L have been described to function as costimulatory molecules by binding such receptors on T cells. Using our recently described system of T-cell stimulator cells we have performed the first study where all these molecules have been assessed and compared regarding their capacity to costimulate proliferation and cytokine production of human T cells. 4-1BBL, which we found to be the most potent molecule in this group, was able to mediate sustained activation and proliferation of human T cells. OX40L and CD70 were also strong inducers of T-cell proliferation, whereas the costimulatory capacity of human GITRL was significantly lower. Importantly CD30L and LIGHT consistently failed to act costimulatory on human T cells, and we therefore suggest that these molecules might be functionally distinct from the costimulatory members of this family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825741      PMCID: PMC2975061          DOI: 10.1002/eji.200838250

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  39 in total

1.  During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.

Authors:  Jenny Hendriks; Yanling Xiao; John W A Rossen; Koenraad F van der Sluijs; Kazuo Sugamura; Naoto Ishii; Jannie Borst
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

2.  Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.

Authors:  Sophia V Derdak; Hans J Kueng; Victoria M Leb; Alina Neunkirchner; Klaus G Schmetterer; Edith Bielek; Otto Majdic; Walter Knapp; Brian Seed; Winfried F Pickl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 3.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

Authors:  Jens Dannull; Zhen Su; David Rizzieri; Benjamin K Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; Johannes Vieweg
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

5.  Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.

Authors:  Mariana Vidric; Woong-Kyung Suh; Umberto Dianzani; Tak W Mak; Tania H Watts
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

6.  Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L.

Authors:  Jacob Bukczynski; Tao Wen; Chao Wang; Natasha Christie; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Colin M Kovacs; Kelly S Macdonald; Mario Ostrowski; Rafick-Pierre Sekaly; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL.

Authors:  Lena Serghides; Jacob Bukczynski; Tao Wen; Chao Wang; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Rafick-Pierre Sekaly; Mario Ostrowski; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

8.  LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice.

Authors:  Bradley J Sedgmen; Wojceich Dawicki; Jennifer L Gommerman; Klaus Pfeffer; Tania H Watts
Journal:  Int Immunol       Date:  2006-03-28       Impact factor: 4.823

9.  Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.

Authors:  Frank Grünebach; Katrin Kayser; Markus M Weck; Martin R Müller; Silke Appel; Peter Brossart
Journal:  Cancer Gene Ther       Date:  2005-09       Impact factor: 5.987

10.  No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation.

Authors:  Katharina Pfistershammer; Christoph Klauser; Winfried F Pickl; Johannes Stöckl; Judith Leitner; Gerhard Zlabinger; Otto Majdic; Peter Steinberger
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

View more
  34 in total

Review 1.  Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire.

Authors:  Christoph R Arnold; Juliane Wolf; Stefan Brunner; Dietmar Herndler-Brandstetter; Beatrix Grubeck-Loebenstein
Journal:  J Clin Immunol       Date:  2011-01-18       Impact factor: 8.317

Review 2.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

3.  ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.

Authors:  Iris Hecht; Amir Toporik; Joseph R Podojil; Ilan Vaknin; Gady Cojocaru; Anat Oren; Elizabeta Aizman; Spencer C Liang; Ling Leung; Yosef Dicken; Amit Novik; Nadav Marbach-Bar; Aziza Elmesmari; Clare Tange; Ashley Gilmour; Donna McIntyre; Mariola Kurowska-Stolarska; Kay McNamee; Judith Leitner; Shirley Greenwald; Liat Dassa; Zurit Levine; Peter Steinberger; Richard O Williams; Stephen D Miller; Iain B McInnes; Eyal Neria; Galit Rotman
Journal:  J Immunol       Date:  2018-02-05       Impact factor: 5.422

4.  Antigen aggregation decides the fate of the allergic immune response.

Authors:  Nadja Zaborsky; Marietta Brunner; Michael Wallner; Martin Himly; Tanja Karl; Robert Schwarzenbacher; Fatima Ferreira; Gernot Achatz
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

Review 5.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

6.  According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.

Authors:  Elia Moreno-Cubero; Dolores Subirá; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid; Antonio Madejón; Joaquín Miquel; Antonio Olveira; Alejandro González-Praetorius; Javier García-Samaniego; Juan-Ramón Larrubia
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

7.  4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.

Authors:  Rajesh K Sharma; Rich-Henry Schabowsky; Abhishek K Srivastava; Kutlu G Elpek; Shravan Madireddi; Hong Zhao; Zhenping Zhong; Robert W Miller; Kathryn J Macleod; Esma S Yolcu; Haval Shirwan
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

Review 8.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 9.  Current challenges for cancer vaccine adjuvant development.

Authors:  William S Bowen; Abhishek K Svrivastava; Lalit Batra; Hampartsoum Barsoumian; Haval Shirwan
Journal:  Expert Rev Vaccines       Date:  2018-02-08       Impact factor: 5.217

10.  Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.

Authors:  Ann Mary Joseph; Ratika Srivastava; Jovanny Zabaleta; Eduardo Davila
Journal:  Cancer Immunol Res       Date:  2016-06-07       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.